April 13, 2021 - 8:28am | By Greg Neft
(New Brunswick, NJ) -- U.S. health agencies are calling for an immediate pause in using the Johnson & Johnson COVID-19 vaccine because of rare blood clots. The FDA and CDC are recommending a temporary halt to the "one and done" vaccine while they review the data. Six women between the ages of 18 and 48 developed blood clots a week or two after they were vaccinated. One woman reportedly died. Further details are expected at a 10 AM Eastern time news conference.
